A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial

Inclusion Criteria: * Age ≥ 60 years; and * Diagnosis of INPH based on the Investigator's clinical judgement based on criteria and testing as described in the INPH Guidelines; and * Evans Ratio ≥ 0.30; and * One positive supplementary test to include large volume Lumbar Puncture or extended CSF drainage per institutional standards; and * History or evidence of gait impairment (such as decreased step height or length,decreased speed, retropulsion as described in the INPH Guidelines) duration ≥ 6 months; and * Participant has the sensory motor skills, communication skills and understanding to comply with the testing and reporting required in the PENS trial; and * Participant is able to give written informed consent, after being properly informed of the nature and risks of the study and prior to engaging in any study-related procedures. Exclusion Criteria: * Unable to walk 10 meters with or without an assistive device; or * Baseline fastest gait velocity\>1 m/sec and fastest gait velocity improvement is ≤ 30% with or without an assistive device; or * Unable to return to the study center for follow up evaluation and shunt programming; or * Participant is not medically cleared for shunt surgery per local standards; or * Secondary NPH. (Prior encephalitis, meningitis, subarachnoid hemorrhage, traumatic brain injury (including concussion) within two years or with brain injury or skull fracture on baseline imaging, brain abscess, brain tumor, obstructive hydrocephalus (including a…